Back

Understanding the Gaps: Clinician Knowledge, Emerging Therapies, and Communication in the Management of Menopausal Vasomotor Symptoms and Sleep Disturbance

including those experiencing vasomotor symptoms (VMS) related to cancer endocrine therapy. The program is designed to strengthen clinicians’ understanding of the neurokinin (NK) pathway and its role in linking VMS with sleep disturbances, while reviewing the clinical evidence for emerging nonhormonal therapies, including NK receptor antagonists, across diverse patient populations. It shares patient perspectives and emphasizes the importance of shared decision-making and evidence-based communication strategies to address risk considerations and individualized treatment planning to support optimal management of menopausal VMS.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Aug 28, 2026
  • Last day to claim credit
    Aug 29, 2027 11 months left